Monopar Therapeutics Inc. (MNPR) NASDAQ
$3.95 1.55 (64.58%)
Market Cap: $13.91M
As of 09/12/24 04:00 PM EDT. Market closed.
Monopar Therapeutics Inc. (MNPR)
NASDAQ
$3.95
1.55 (64.58%)
Market Cap: $13.91M
As of 09/12/24 04:00 PM EDT. Market closed.
Add to Portfolio
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc
Full Time Employees
9
CEO Compensation (Base)
$504,488
CEO Compensation (Total)
$1.59M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc
Full Time Employees
9
CEO Compensation (Base)
$504,488
CEO Compensation (Total)
$1.59M
Address
1000 Skokie Boulevard, IL, Wilmette, 60091.
PRICE CHART FOR MONOPAR THERAPEUTICS INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.15
Previous Close
$2.40
Days Range
$3.17 - $5.44
52 week range
$1.37 - $8.65
Volume
40,888,377
Avg. Volume (30 days)
60,109
Market Cap
$13.91M
Dividend Yield
-
P/E
(1.72)
Shares Outstanding
3,520,370
Open
$5.15
Previous Close
$2.40
Days Range
$3.17 - $5.44
52 week range
$1.37 - $8.65
Volume
40,888,377
Avg. Volume (30 days)
60,109
Market Cap
$13.91M
Dividend Yield
-
P/E
(1.72)
Shares Outstanding
3,520,370
FINANCIAL STATEMENTS FOR MONOPAR THERAPEUTICS INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR MONOPAR THERAPEUTICS INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Cittadine Andrew | Chief Operating Officer | Jun 30, 2024 | Option Exercise | $0.73 | 2,019 | 1,476 | 193,065 | Jul 02, 2024, 06:12 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Jun 30, 2024 | Option Exercise | $0.73 | 2,998 | 2,192 | 57,429 | Jul 02, 2024, 06:08 PM |
| Robinson Chandler | Chief Executive Officer | Jun 30, 2024 | Option Exercise | $0.73 | 8,684 | 6,348 | 265,923 | Jul 02, 2024, 06:07 PM |
| Cittadine Andrew | Chief Operating Officer | Jun 20, 2024 | Buy | $0.74 | 20,508 | 15,254 | 186,132 | Jun 21, 2024, 05:16 PM |
| Cittadine Andrew | Chief Operating Officer | Jun 18, 2024 | Buy | $0.86 | 12,000 | 10,320 | 165,624 | Jun 21, 2024, 05:16 PM |
| Cittadine Andrew | Chief Operating Officer | Jun 17, 2024 | Buy | $0.90 | 12,000 | 10,799 | 153,624 | Jun 17, 2024, 06:08 PM |
| Cittadine Andrew | Chief Operating Officer | Jun 14, 2024 | Buy | $0.93 | 12,000 | 11,176 | 141,624 | Jun 17, 2024, 06:08 PM |
| Cittadine Andrew | Chief Operating Officer | Jun 13, 2024 | Buy | $0.91 | 12,000 | 10,920 | 129,624 | Jun 17, 2024, 06:08 PM |
| Cittadine Andrew | Chief Operating Officer | Jun 04, 2024 | Buy | $0.78 | 12,000 | 9,360 | 117,624 | Jun 05, 2024, 06:12 PM |
| Cittadine Andrew | Chief Operating Officer | Jun 03, 2024 | Buy | $0.76 | 12,000 | 9,120 | 105,624 | Jun 05, 2024, 06:12 PM |
| Cittadine Andrew | Chief Operating Officer | May 31, 2024 | Buy | $0.64 | 12,000 | 7,732 | 93,624 | May 31, 2024, 04:56 PM |
| Cittadine Andrew | Chief Operating Officer | May 30, 2024 | Buy | $0.64 | 12,000 | 7,676 | 81,624 | May 31, 2024, 04:56 PM |
| Cittadine Andrew | Chief Operating Officer | May 29, 2024 | Buy | $0.64 | 12,000 | 7,643 | 69,624 | May 31, 2024, 04:56 PM |
| Robinson Chandler | Chief Executive Officer | May 28, 2024 | Option Exercise | $0.00 | 84,000 | 84 | 250,131 | May 30, 2024, 06:10 PM |
| Cittadine Andrew | Chief Operating Officer | Mar 31, 2024 | Option Exercise | $0.68 | 3,098 | 2,110 | 57,624 | Apr 02, 2024, 08:35 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Mar 31, 2024 | Option Exercise | $0.68 | 4,082 | 2,780 | 50,470 | Apr 02, 2024, 08:33 PM |
| Robinson Chandler | Chief Executive Officer | Mar 31, 2024 | Option Exercise | $0.68 | 7,172 | 4,884 | 166,131 | Apr 02, 2024, 08:33 PM |
| Cittadine Andrew | Chief Operating Officer | Dec 31, 2023 | Option Exercise | $0.34 | 3,098 | 1,054 | 51,770 | Jan 03, 2024, 07:39 PM |
| Robinson Chandler | Chief Executive Officer | Jan 01, 2024 | Option Exercise | $0.34 | 2,327 | 792 | 148,829 | Jan 03, 2024, 07:36 PM |
| Robinson Chandler | Chief Executive Officer | Dec 31, 2023 | Option Exercise | $0.34 | 8,469 | 2,881 | 144,432 | Jan 03, 2024, 07:36 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Dec 31, 2023 | Option Exercise | $0.34 | 4,073 | 1,386 | 43,870 | Jan 03, 2024, 07:34 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Jan 01, 2024 | Option Exercise | $0.34 | 505 | 172 | 44,596 | Jan 03, 2024, 07:34 PM |
| Robinson Chandler | Chief Executive Officer | Sep 30, 2023 | Option Exercise | $0.62 | 7,172 | 4,446 | 128,427 | Oct 03, 2023, 07:37 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Sep 30, 2023 | Option Exercise | $0.62 | 3,444 | 2,135 | 37,986 | Oct 03, 2023, 07:36 PM |
| Cittadine Andrew | Chief Operating Officer | Sep 30, 2023 | Option Exercise | $0.62 | 2,624 | 1,627 | 45,916 | Oct 03, 2023, 07:30 PM |
| Cittadine Andrew | Chief Operating Officer | Jun 30, 2023 | Option Exercise | $0.86 | 4,057 | 3,469 | 39,587 | Jul 03, 2023, 06:51 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Jun 30, 2023 | Option Exercise | $0.86 | 5,104 | 4,364 | 31,474 | Jul 03, 2023, 06:46 PM |
| Robinson Chandler | Chief Executive Officer | Jun 30, 2023 | Option Exercise | $0.86 | 10,269 | 8,780 | 111,125 | Jul 03, 2023, 06:45 PM |
| Robinson Chandler | Chief Executive Officer | Mar 31, 2023 | Option Exercise | $1.39 | 4,286 | 5,958 | 86,355 | Apr 04, 2023, 05:17 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Mar 31, 2023 | Option Exercise | $1.39 | 1,842 | 2,560 | 21,732 | Apr 04, 2023, 05:16 PM |
| Cittadine Andrew | Chief Operating Officer | Dec 31, 2022 | Option Exercise | $2.37 | 1,406 | 3,332 | 26,894 | Jan 03, 2023, 04:07 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Jan 01, 2023 | Option Exercise | $2.37 | 502 | 1,190 | 18,507 | Jan 03, 2023, 04:03 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Dec 31, 2022 | Option Exercise | $2.37 | 2,067 | 4,899 | 17,779 | Jan 03, 2023, 04:03 PM |
| Robinson Chandler | Chief Executive Officer | Dec 31, 2022 | Option Exercise | $2.37 | 4,814 | 11,409 | 72,334 | Jan 03, 2023, 03:59 PM |
| Robinson Chandler | Chief Executive Officer | Jan 01, 2023 | Option Exercise | $2.37 | 2,327 | 5,515 | 76,730 | Jan 03, 2023, 03:59 PM |
| Cittadine Andrew | Chief Operating Officer | Nov 15, 2022 | Buy | $3.15 | 10,000 | 31,500 | 24,238 | Nov 16, 2022, 04:58 PM |
| Cittadine Andrew | Chief Operating Officer | Nov 14, 2022 | Buy | $3.00 | 6,053 | 18,159 | 14,238 | Nov 16, 2022, 04:58 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Sep 30, 2022 | Option Exercise | $1.52 | 1,753 | 2,665 | 14,779 | Oct 03, 2022, 07:59 PM |
| Robinson Chandler | Chief Executive Officer | Sep 30, 2022 | Option Exercise | $1.52 | 4,077 | 6,197 | 63,236 | Oct 03, 2022, 07:55 PM |
| Cittadine Andrew | Chief Operating Officer | Sep 30, 2022 | Option Exercise | $1.52 | 1,191 | 1,810 | 8,185 | Oct 03, 2022, 07:42 PM |
| Cittadine Andrew | Chief Operating Officer | Jun 30, 2022 | Option Exercise | $2.30 | 2,812 | 6,465 | 5,313 | Jul 01, 2022, 04:17 PM |
| Robinson Chandler | Chief Executive Officer | Jun 30, 2022 | Option Exercise | $2.30 | 6,999 | 16,091 | 53,402 | Jul 01, 2022, 04:07 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Jun 30, 2022 | Option Exercise | $2.30 | 3,083 | 7,088 | 11,466 | Jul 01, 2022, 04:05 PM |
| Robinson Chandler | Chief Executive Officer | Mar 31, 2022 | Option Exercise | $2.55 | 1,155 | 2,945 | 36,519 | Apr 01, 2022, 05:28 PM |
| Mazar Andrew Paul | Chief Scientific Officer | Mar 31, 2022 | Option Exercise | $2.55 | 471 | 1,201 | 22,125 | Apr 01, 2022, 05:28 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Mar 31, 2022 | Option Exercise | $2.55 | 500 | 1,275 | 5,636 | Apr 01, 2022, 05:28 PM |
| Mazar Andrew Paul | Chief Scientific Officer | Jan 01, 2022 | Option Exercise | $3.21 | 671 | 2,154 | 20,990 | Jan 04, 2022, 02:49 PM |
| Mazar Andrew Paul | Chief Scientific Officer | Dec 31, 2021 | Option Exercise | $3.21 | 556 | 1,785 | 19,724 | Jan 04, 2022, 02:40 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Jan 01, 2022 | Option Exercise | $3.21 | 505 | 1,621 | 4,915 | Jan 04, 2022, 02:31 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Dec 31, 2021 | Option Exercise | $3.21 | 501 | 1,608 | 4,189 | Jan 04, 2022, 02:27 PM |
| Robinson Chandler | Chief Executive Officer | Jan 01, 2022 | Option Exercise | $3.21 | 2,327 | 7,470 | 33,733 | Jan 04, 2022, 02:17 PM |
| Robinson Chandler | Chief Executive Officer | Dec 31, 2021 | Option Exercise | $3.21 | 1,364 | 4,378 | 29,336 | Jan 04, 2022, 02:07 PM |
| Mazar Andrew Paul | Chief Scientific Officer | Sep 30, 2021 | Option Exercise | $4.87 | 471 | 2,294 | 18,674 | Oct 01, 2021, 07:31 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Sep 30, 2021 | Option Exercise | $4.87 | 423 | 2,060 | 3,469 | Oct 01, 2021, 07:29 PM |
| Robinson Chandler | Chief Executive Officer | Sep 30, 2021 | Option Exercise | $4.87 | 1,155 | 5,625 | 26,759 | Oct 01, 2021, 07:24 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Jun 30, 2021 | Option Exercise | $5.89 | 823 | 4,847 | 2,671 | Jul 02, 2021, 05:13 PM |
| Mazar Andrew Paul | Chief Scientific Officer | Jun 30, 2021 | Option Exercise | $5.89 | 942 | 5,548 | 17,539 | Jul 02, 2021, 05:11 PM |
| Robinson Chandler | Chief Executive Officer | Jun 30, 2021 | Option Exercise | $5.89 | 2,310 | 13,606 | 23,973 | Jul 02, 2021, 05:10 PM |
| Tactic Pharma LLC | 10% Owner | Feb 11, 2021 | Sale | $14.64 | 125,000 | 1,830,620 | 249,200 | Feb 16, 2021, 07:35 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Jan 01, 2021 | Option Exercise | $6.12 | 504 | 3,084 | 1,052 | Jan 05, 2021, 06:23 PM |
| Robinson Chandler | Chief Executive Officer | Jan 01, 2021 | Option Exercise | $6.12 | 2,327 | 14,241 | 18,400 | Jan 05, 2021, 12:00 AM |
| Mazar Andrew Paul | Chief Scientific Officer | Jan 01, 2021 | Option Exercise | $6.12 | 671 | 4,107 | 15,269 | Jan 05, 2021, 12:00 AM |
| Hendricks Diane | 10% Owner | Dec 18, 2019 | Buy | $8.00 | 468,750 | 3,750,000 | 468,750 | Dec 20, 2019, 07:10 PM |
| Tactic Pharma LLC | 10% Owner | Dec 18, 2019 | Buy | $8.00 | 125,000 | 1,000,000 | 291,667 | Dec 20, 2019, 06:33 PM |
| Leo Karl | 10% Owner | Dec 18, 2019 | Buy | $8.00 | 314 | 2,512 | 314 | Dec 20, 2019, 06:32 PM |
| Leo Karl | 10% Owner | Dec 18, 2019 | Buy | $8.00 | 156,250 | 1,250,000 | 156,250 | Dec 20, 2019, 06:32 PM |
| Tsuchimoto Kim R | Chief Financial Officer | Dec 18, 2019 | Buy | $8.00 | 325 | 2,600 | 325 | Dec 20, 2019, 06:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Cittadine Andrew | Chief Operating Officer | 06/30/2024 | 1,476 |
| Tsuchimoto Kim R | Chief Financial Officer | 06/30/2024 | 2,192 |
| Robinson Chandler | Chief Executive Officer | 06/30/2024 | 6,348 |
| Cittadine Andrew | Chief Operating Officer | 06/20/2024 | 15,254 |
| Cittadine Andrew | Chief Operating Officer | 06/18/2024 | 10,320 |
| Cittadine Andrew | Chief Operating Officer | 06/17/2024 | 10,799 |
| Cittadine Andrew | Chief Operating Officer | 06/14/2024 | 11,176 |
| Cittadine Andrew | Chief Operating Officer | 06/13/2024 | 10,920 |
| Cittadine Andrew | Chief Operating Officer | 06/04/2024 | 9,360 |
| Cittadine Andrew | Chief Operating Officer | 06/03/2024 | 9,120 |
| Cittadine Andrew | Chief Operating Officer | 05/31/2024 | 7,732 |
| Cittadine Andrew | Chief Operating Officer | 05/30/2024 | 7,676 |
| Cittadine Andrew | Chief Operating Officer | 05/29/2024 | 7,643 |
| Robinson Chandler | Chief Executive Officer | 05/28/2024 | 84 |
| Cittadine Andrew | Chief Operating Officer | 03/31/2024 | 2,110 |
| Tsuchimoto Kim R | Chief Financial Officer | 03/31/2024 | 2,780 |
| Robinson Chandler | Chief Executive Officer | 03/31/2024 | 4,884 |
| Cittadine Andrew | Chief Operating Officer | 12/31/2023 | 1,054 |
| Robinson Chandler | Chief Executive Officer | 01/01/2024 | 792 |
| Robinson Chandler | Chief Executive Officer | 12/31/2023 | 2,881 |
| Tsuchimoto Kim R | Chief Financial Officer | 12/31/2023 | 1,386 |
| Tsuchimoto Kim R | Chief Financial Officer | 01/01/2024 | 172 |
| Robinson Chandler | Chief Executive Officer | 09/30/2023 | 4,446 |
| Tsuchimoto Kim R | Chief Financial Officer | 09/30/2023 | 2,135 |
| Cittadine Andrew | Chief Operating Officer | 09/30/2023 | 1,627 |
| Cittadine Andrew | Chief Operating Officer | 06/30/2023 | 3,469 |
| Tsuchimoto Kim R | Chief Financial Officer | 06/30/2023 | 4,364 |
| Robinson Chandler | Chief Executive Officer | 06/30/2023 | 8,780 |
| Robinson Chandler | Chief Executive Officer | 03/31/2023 | 5,958 |
| Tsuchimoto Kim R | Chief Financial Officer | 03/31/2023 | 2,560 |
| Cittadine Andrew | Chief Operating Officer | 12/31/2022 | 3,332 |
| Tsuchimoto Kim R | Chief Financial Officer | 01/01/2023 | 1,190 |
| Tsuchimoto Kim R | Chief Financial Officer | 12/31/2022 | 4,899 |
| Robinson Chandler | Chief Executive Officer | 12/31/2022 | 11,409 |
| Robinson Chandler | Chief Executive Officer | 01/01/2023 | 5,515 |
| Cittadine Andrew | Chief Operating Officer | 11/15/2022 | 31,500 |
| Cittadine Andrew | Chief Operating Officer | 11/14/2022 | 18,159 |
| Tsuchimoto Kim R | Chief Financial Officer | 09/30/2022 | 2,665 |
| Robinson Chandler | Chief Executive Officer | 09/30/2022 | 6,197 |
| Cittadine Andrew | Chief Operating Officer | 09/30/2022 | 1,810 |
| Cittadine Andrew | Chief Operating Officer | 06/30/2022 | 6,465 |
| Robinson Chandler | Chief Executive Officer | 06/30/2022 | 16,091 |
| Tsuchimoto Kim R | Chief Financial Officer | 06/30/2022 | 7,088 |
| Robinson Chandler | Chief Executive Officer | 03/31/2022 | 2,945 |
| Mazar Andrew Paul | Chief Scientific Officer | 03/31/2022 | 1,201 |
| Tsuchimoto Kim R | Chief Financial Officer | 03/31/2022 | 1,275 |
| Mazar Andrew Paul | Chief Scientific Officer | 01/01/2022 | 2,154 |
| Mazar Andrew Paul | Chief Scientific Officer | 12/31/2021 | 1,785 |
| Tsuchimoto Kim R | Chief Financial Officer | 01/01/2022 | 1,621 |
| Tsuchimoto Kim R | Chief Financial Officer | 12/31/2021 | 1,608 |
| Robinson Chandler | Chief Executive Officer | 01/01/2022 | 7,470 |
| Robinson Chandler | Chief Executive Officer | 12/31/2021 | 4,378 |
| Mazar Andrew Paul | Chief Scientific Officer | 09/30/2021 | 2,294 |
| Tsuchimoto Kim R | Chief Financial Officer | 09/30/2021 | 2,060 |
| Robinson Chandler | Chief Executive Officer | 09/30/2021 | 5,625 |
| Tsuchimoto Kim R | Chief Financial Officer | 06/30/2021 | 4,847 |
| Mazar Andrew Paul | Chief Scientific Officer | 06/30/2021 | 5,548 |
| Robinson Chandler | Chief Executive Officer | 06/30/2021 | 13,606 |
| Tactic Pharma LLC | 10% Owner | 02/11/2021 | 1,830,620 |
| Tsuchimoto Kim R | Chief Financial Officer | 01/01/2021 | 3,084 |
| Robinson Chandler | Chief Executive Officer | 01/01/2021 | 14,241 |
| Mazar Andrew Paul | Chief Scientific Officer | 01/01/2021 | 4,107 |
| Hendricks Diane | 10% Owner | 12/18/2019 | 3,750,000 |
| Tactic Pharma LLC | 10% Owner | 12/18/2019 | 1,000,000 |
| Leo Karl | 10% Owner | 12/18/2019 | 2,512 |
| Leo Karl | 10% Owner | 12/18/2019 | 1,250,000 |
| Tsuchimoto Kim R | Chief Financial Officer | 12/18/2019 | 2,600 |
Load More Insider Transactions
FUNDS WITH A POSITION IN MONOPAR THERAPEUTICS INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 60,036 | 0% | 45.72% | Other |
CHANGE IN SHARES OUTSTANDING FOR MONOPAR THERAPEUTICS INC.
STOCK BUYBACKS FOR MONOPAR THERAPEUTICS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
9.15%
1Q
09/30/2023
13.18%
2Q
06/30/2023
19.07%
3Q
03/31/2023
21.93%
4Q
12/31/2022
24.07%
5Q
09/30/2022
25.29%
6Q
06/30/2022
26.50%
7Q
03/31/2022
26.78%
8Q
12/31/2021
26.95%
9Q
09/30/2021
27.00%
10Q
06/30/2021
27.13%
11Q
03/31/2021
31.64%
12Q
12/31/2020
39.49%
13Q
09/30/2020
43.75%
14Q
06/30/2020
50.07%
15Q
03/31/2020
50.64%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MONOPAR THERAPEUTICS INC.
LOADING...